Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation

J Invest Dermatol. 2018 Mar;138(3):669-678. doi: 10.1016/j.jid.2017.10.007. Epub 2017 Dec 6.

Abstract

Accumulating evidence has described the involvement of mTORC1 signaling in pigmentation regulation; however, the precise mechanism is not fully understood. Here, we generated mice with conditional deletion of the mTORC1 suppressor Tsc2 in melanocytes. It resulted in constitutive hyperactivation of mTORC1 and reduced skin pigmentation. Mechanistically, neither the number of melanocytes nor the expression of melanogenesis-related enzymes was decreased; however, endoplasmic reticulum and mitochondrial oxidative stress and lower melanization in melanosomes were observed. By contrast, abrogation of mTORC1 by rapamycin completely reversed the reduced pigmentation, and alleviation of endoplasmic reticulum stress by SMER28 or 4-phenylbutyrate (PBA) or alleviation of mitochondrial oxidative stress by administration of adenosine triphosphate partially reversed the reduced pigmentation in these mice. In addition, we showed that these mechanisms were involved in reduced pigmentation of TSC2 small interfering RNA-transfected cultured human primary melanocytes and skin lesions of patients with the TSC gene mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endoplasmic Reticulum / metabolism*
  • Humans
  • Hypopigmentation / etiology
  • Hypopigmentation / metabolism*
  • Mechanistic Target of Rapamycin Complex 1 / physiology*
  • Melanins / biosynthesis
  • Melanocytes / metabolism
  • Mice
  • Mice, Knockout
  • Mitochondria / metabolism*
  • Oxidative Stress*
  • Sirolimus / pharmacology
  • Skin Pigmentation*
  • TOR Serine-Threonine Kinases / physiology
  • Tuberous Sclerosis Complex 2 Protein / physiology

Substances

  • Melanins
  • Tsc2 protein, mouse
  • Tuberous Sclerosis Complex 2 Protein
  • mTOR protein, mouse
  • Mechanistic Target of Rapamycin Complex 1
  • TOR Serine-Threonine Kinases
  • Sirolimus